Research Areas
Today's research for tomorrow's
health breakthroughs
With more than 600 clinical trials completed over three decades, we've been the trusted choice for Phase 1-4 clinical trials involving thousands of participants. Our full-time, dedicated, board-certified investigators work with a team of clinical trial professionals in our state-of-the-art facility to complete studies in a wide range of therapeutic areas.
Primary specialities
Diabetes
Type 1 Diabetes
Medical Devices
High Cholesterol
Weight Loss
Type 2 Diabetes
Low Testosterone
NASH
Early Phase
Vaccines
Ophthalmology
Healthy Normal
Previous studies
Learn more about some of the studies we've completed in a wide range of therapeutic areas.
A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Immunogenicity of An Investigational Vaccie for SARS-COV-2 Targeting A Variant Spike Protein in Unvaccinated or Previously Vaccinated Healthy Adults
A Phase 2/3 Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of An Investigational Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older
A Phase 3 Parallel Design, Open Label, Randomized Controlled Study to Evaluate the Efficacy and Safety of An Investigational Weekly Insulin Compared to a Marketed Insulin in Adults with Type II Diabetes on Multiple Daily Injections
A Phase 3, Multicenter, Randomized, Parallel Design, Open Label Study to Evaluate the Efficacy and Safety of An Investigational Weekly Insulin Compared with A Marketing Insulin in Participants With Type I Diabetes Treated with Multiple Daily Injection Therapy
A Phase 1b Study of An Investigational Medication in Patients With Type I Diabetes
A Multicenter, Randomized, Double-Blind, Crossover, Phase 2 Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy with An Investigational Medication Compared to Levothyroxine in Patients With Primary Hypothyroidism
A Comparator Study of Hemoglobin A1c Samples Collected Using an Investigational Blood Collection Device
Accuracy Study off An Interstitial Fluid Glucose Sensor
Clinical Evaluation of the Glucose Test in Capillary Specimens Using An Investigational Analyzer
Safety Evaluation of An Investigational Closed Loop System in Type 1 Adult and Pediatric Subjects Utilizing An Approved Short Acting Insulin
Evaluation of An Investigational Closed Loop Insulin Delivery System in Type 1 Adult and Pediatric Subjects using an Approved Insulin
An In-Home Study with An Investigational Insulin Delivery System in Subjects with Adult Type 2 Diabetes Who Are Insulin Requiring
Characterization Study of An Investigational Glucose Monitoring System Using Capillary Glucose Reference
A Pilot Study of the Feasibility and Accuracy of An Investigational Continuous Glucose Monitoring System
Evaluation of a Sensor for Continuous Glucose Monitoring of Glucose Levels Within the Interstitial Fluid over a 14-Day Wearing Period
Method Comparison/User Evaluation of An Investigational Self-Monitoring Blood Glucose System
An Early Feasibility Study to Evaluate the Safety and Functionality of an Individual Accruing Data Algorithm with An Investigational Medication in Adult Participants with Type 2 Diabetes
A Phase 3 Multicenter Randomized Parallel Design, Open Label Trial to Evaluate the Efficacy and Safety of An Investigational Medication Compared to An Approved Insulin in Participants with Type 2 Diabetes Currently Treated with Basal Insulin
A 52-Week Study Comparing the Efficacy and Safety of A Once Weekly Investigational Medication and Daily Insulin Glargine Combined with Insulin Aspart, Both Treatment Arms With or Without Oral Anti-Diabetic Drugs in Participants With Type 2 Diabetes Inadequately Controlled With Daily Basal Insulin
Precision Study of in An Investigational Point of Care Device Using Whole Blood
What our clients are saying
- Senior Manager, Clinical Research Programs, A global leader in medical technology company